Cargando…
Effects of probiotic bacterium Weissella cibaria CMU on periodontal health and microbiota: a randomised, double-blind, placebo-controlled trial
BACKGROUND: Weissella cibaria CMU (oraCMU) has been commercially available in the market for several years as oral care probiotics. The present study aimed to evaluate the effects of oraCMU-containing tablets on periodontal health and oral microbiota. METHODS: A randomised, double-blind, placebo-con...
Autores principales: | Kang, Mi-Sun, Lee, Dong-Suk, Lee, Seung-Ah, Kim, Myoung-Suk, Nam, Seoul-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469353/ https://www.ncbi.nlm.nih.gov/pubmed/32878603 http://dx.doi.org/10.1186/s12903-020-01231-2 |
Ejemplares similares
-
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Acidogenic Potential of Dental Biofilms through a Tablet Containing Weissella cibaria CMU
por: Kang, Mi-Sun, et al.
Publicado: (2021) -
Improvement of halitosis by probiotic bacterium Weissella cibaria CMU: A randomized controlled trial
por: Han, Hee-seung, et al.
Publicado: (2023) -
Comparative Study on the Characteristics of Weissella cibaria CMU and Probiotic Strains for Oral Care
por: Jang, Hye-Jin, et al.
Publicado: (2016) -
Characterization of Antibacterial Cell-Free Supernatant from Oral Care Probiotic Weissella cibaria, CMU
por: Lim, Hae-Soon, et al.
Publicado: (2018) -
Toxicological and safety evaluations of Weissella cibaria strain CMU in animal toxicity and genotoxicity
por: Dolan, Laurie C., et al.
Publicado: (2022)